Lataa...
An expanded population of pathogenic regulatory T-cells in giant cell arteritis is abrogated by IL-6 blockade therapy
OBJECTIVES: Randomized-controlled trials have recently proven the efficacy of the interleukin-6 receptor antagonist tocilizumab (TCZ) in GCA. However, the mechanism of action of IL-6 blockade in this disease is unknown. Moreover, the role of regulatory T-cells (Treg) in the pathogenesis of GCA remai...
Tallennettuna:
| Julkaisussa: | Ann Rheum Dis |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5744591/ https://ncbi.nlm.nih.gov/pubmed/27927642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2016-210070 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|